| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular Physiology and Biophysics, University of Vermont, College of Medicine, Burlington, Vermont
Correspondence: Address reprint requests to Peter VanBuren, University of Vermont, College of Medicine, 105 HRSF Building, 149 Beaumont Ave., Burlington, VT 05405. Tel.: 802-847-3734; Fax: 802-656-0747; E-mail: vanburen{at}physiology.med.uvm.edu.
The current study was undertaken to investigate the relative contribution of calcium and myosin binding to thin filament activation. Using the in vitro motility assay, myosin strong binding to the thin filament was controlled by three mechanisms: 1), varying the myosin concentration of the motility surface, and adding either 2), inorganic phosphate (Pi) or 3), adenosine diphosphate (ADP) to the motility solutions. At saturating myosin conditions, Pi had no effect on thin filament motility. However, at subsaturating myosin concentrations, velocity was reduced at maximal and submaximal calcium in the presence of Pi. Adding ADP to the motility buffers reduced thin filament sliding velocity but increased the pCa50 of the thin filament. Thus by limiting or increasing myosin strong binding (with the addition of Pi and ADP, respectively), the calcium concentration at which half maximal activation of the thin filament is achieved can be modulated. In experiments without ADP or Pi, the myosin concentration on the motility surface required to reach maximal velocity inversely correlated with the level of calcium activation. Through this approach, we demonstrate that myosin strong binding is essential for thin filament activation at both maximal and submaximal calcium levels, with the relative contribution of myosin strong binding being greatest at submaximal calcium. Furthermore, under conditions in which myosin strong binding is not rate limiting (i.e., saturating myosin conditions), our data suggest that a modulation of myosin cross-bridge kinetics is likely responsible for the graded response to calcium observed in the in vitro motility assay.
This article has been cited by other articles:
![]() |
M. V. Razumova, J. F. Shaffer, A.-Y. Tu, G. V. Flint, M. Regnier, and S. P. Harris Effects of the N-terminal Domains of Myosin Binding Protein-C in an in Vitro Motility Assay: EVIDENCE FOR LONG-LIVED CROSS-BRIDGES J. Biol. Chem., November 24, 2006; 281(47): 35846 - 35854. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Kad, S. Kim, D. M. Warshaw, P. VanBuren, and J. E. Baker Single-myosin crossbridge interactions with actin filaments regulated by troponin-tropomyosin PNAS, November 22, 2005; 102(47): 16990 - 16995. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Clemmens, M. Entezari, D. A Martyn, and M. Regnier Different effects of cardiac versus skeletal muscle regulatory proteins on in vitro measures of actin filament speed and force J. Physiol., August 1, 2005; 566(3): 737 - 746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |